Christopher Whitmore
Plus aucun poste en cours
Profil
Christopher Whitmore worked as a Senior Director-Finance & Controller at Talphera, Inc. from 2011 to 2015.
Prior to that, he was a Controller at Sangamo Therapeutics, Inc. from 2008 to 2011, and an Audit Manager at KPMG LLP from 2002 to 2008.
He also held the position of Vice President-Finance & Administration at Immune Design Corp.
Mr. Whitmore received an undergraduate degree from the University of California, Santa Barbara.
Anciens postes connus de Christopher Whitmore
| Sociétés | Poste | Fin |
|---|---|---|
| TALPHERA, INC. | Comptroller/Controller/Auditor | 01/04/2015 |
| SANGAMO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/05/2011 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2008 |
| IMMUNE DESIGN CORP | Directeur Administratif | - |
Formation de Christopher Whitmore
| University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TALPHERA, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |